You are here

EpiPen

FDA approves nasal spray alternative to EpiPen for allergic reactions

Reuters

Sun, 08/11/24 - 01:07 pm

ARS Pharmaceuticals

allergic reactions

Pfizer inks another EpiPen antitrust settlement, this one worth $50

Fierce Pharma

Wed, 10/11/23 - 11:48 pm

class action lawsuits

Viatris maintains legal winning streak with yet another EpiPen antitrust victory

Fierce Pharma

Mon, 04/3/23 - 10:51 pm

Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaints

Fierce Pharma

Tue, 07/27/21 - 04:27 pm

Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial

Fierce Pharma

Fri, 06/25/21 - 11:09 am

Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal

Investors Business Daily

Sat, 09/28/19 - 05:16 pm

Medicaid misclassification bill inspired by EpiPen snafu passes Congress

Fierce Pharma

Wed, 04/3/19 - 12:24 pm

misclassification

Teva aims for 25% of U.S. EpiPen market by 2020

Drug Delivery Business News

Tue, 02/19/19 - 10:22 am

Teva Pharmaceutical

EpiPen shortages seen in Canada, UK but U.S. supply intact

Yahoo/Reuters

Sat, 04/14/18 - 01:23 pm

Express Scripts covers Mylan’s EpiPen on 2018 formulary, excluding rivals

Drug Delivery Business News

Tue, 08/1/17 - 11:11 am

Express Scripts

EpiPen May Retain Potency up to Four Years After Expiration Date

Xtalks

Sat, 05/13/17 - 10:02 am

expiration dates

Meet the lawyer trying to pry drug pricing secrets out of Big Pharma

Stat

Thu, 04/20/17 - 09:02 pm

EpiPen competitor Auvi-Q comes back Feb. 14 with a pricing scheme that will blow your mind

CNBC

Thu, 01/19/17 - 11:28 pm

Mylan refuses to testify at Senate hearing about EpiPen rebates to Medicaid

Stat/Pharmalot

Tue, 11/22/16 - 12:19 pm

Senators demand Mylan repay $50 million to the Pentagon for EpiPen

Stat/Pharmalot

Tue, 11/8/16 - 04:26 pm

Department of Defense

Timeline of a crisis: How Mylan responded to the EpiPen controversy

Medical Marketing and Media

Tue, 11/1/16 - 10:06 am

EpiPen rival Auvi-Q will return to market next year

Thu, 10/27/16 - 04:04 pm

EpiPen prescriptions continue to climb, but market share dropped

Stat/Pharmalot

Tue, 10/25/16 - 04:00 pm

EpiPen Shows A Path To Solve The Bigger Drug Pricing Challenge

Forbes

Mon, 10/24/16 - 09:33 am

EpiPen Maker Mylan Agrees To $465 Million Settlement With DOJ

Forbes

Fri, 10/7/16 - 10:30 pm

Pages